To investigate the impact of blood glucose control levels on cardiac function recovery and long-term prognosis in elderly patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) from January 2023 to January 2024.
Key Findings:
Poor baseline glucose control correlated with higher diabetes prevalence (78.05% vs. 20.51%, P < 0.001) and worse outcomes.
The group with persistent poor control had the highest MACE incidence (34.62%) and lowest quality of life scores.
Postoperative improvement in glucose control led to outcomes similar to those with continuous good control, indicating a significant prognostic factor.
Interpretation:
Continuous blood glucose management after PCI significantly enhances prognosis and quality of life in elderly AMI patients, emphasizing the importance of dynamic monitoring for better clinical outcomes.
Limitations:
Retrospective design may introduce bias.
Limited sample size may affect generalizability.
Potential confounding factors affecting outcomes were not fully addressed.
Conclusion:
Dynamic monitoring and management of blood glucose levels post-PCI are crucial for improving cardiac recovery and quality of life in elderly AMI patients.
